title: Re: Chen H. et al: Efficacy of Daily Low-dose Tadalafil for Treating Overactive Bladder: Results of a Randomized, Double-blind, Placebo-controlled Trial (Urology 2016;100:59-64).
authors.affiliation: Institute of Urology, Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China.
authors.forename: Yubo
authors.initials: Y
authors.lastname: Yang
authors.affiliation: Institute of Urology, Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China.
authors.forename: Yunjin
authors.initials: Y
authors.lastname: Bai
authors.affiliation: Institute of Urology, Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China.
authors.forename: Xiaoming
authors.initials: X
authors.lastname: Wang
authors.affiliation: Institute of Urology, Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China.
authors.forename: Ping
authors.initials: P
authors.lastname: Han
mesh_terms: D004311:Double-Blind Method; D006801:Humans; D018727:Muscarinic Antagonists; D000068581:Tadalafil; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive
chemical_list: D018727:Muscarinic Antagonists; D000068581:Tadalafil